Angelman syndrome: genes and variants
Explore variant evidence for Angelman syndrome across 3 analyzed proteins (UBE3A, CDKL5, MECP2). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 30 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Angelman syndrome
UBE3A: Ubiquitin-protein ligase E3A
Its ubiquitin-ligase activity controls turnover of selected neuronal proteins and is subject to maternal-specific expression in many neurons. Loss of the maternal allele causes Angelman syndrome, while increased dosage contributes to neurodevelopmental abnormalities in 15q11-q13 duplication.
14 ClinVar pathogenic / likely pathogenic and 32 uncertain variants in UBE3A have source records linked to Angelman syndrome. Association strength is not clinical gene validity.
CDKL5: Cyclin-dependent kinase-like 5
It phosphorylates neuronal substrates involved in synapse development, cytoskeletal organization, and signaling during early brain maturation. Loss-of-function variants cause CDKL5 deficiency disorder with very early epilepsy and severe developmental impairment.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CDKL5 have source records linked to Angelman syndrome. Association strength is not clinical gene validity.
MECP2: Methyl-CpG-binding protein 2
It interprets DNA methylation and organizes transcriptional and chromatin states that are especially important in mature neurons. Loss-of-function variants cause Rett syndrome, whereas increased dosage causes MECP2 duplication syndrome.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MECP2 have source records linked to Angelman syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Angelman syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| UBE3A T129K | 129 | Pathogenic / likely pathogenic (★★★) | |
| UBE3A P850L | 850 | HECT | Pathogenic / likely pathogenic (★★) |
| UBE3A G736D | 736 | Pathogenic / likely pathogenic (★) | |
| UBE3A R337W | 337 | Pathogenic / likely pathogenic (★) | |
| UBE3A D235V | 235 | Pathogenic / likely pathogenic | |
| UBE3A L260H | 260 | Pathogenic / likely pathogenic | |
| UBE3A L286W | 286 | Pathogenic / likely pathogenic | |
| UBE3A L458P | 458 | Interaction with HCV core protein | Pathogenic / likely pathogenic |
| UBE3A P481L | 481 | Interaction with HCV core protein | Pathogenic / likely pathogenic |
| UBE3A R500P | 500 | Interaction with HCV core protein | Pathogenic / likely pathogenic |
| UBE3A M589K | 589 | Pathogenic / likely pathogenic | |
| UBE3A E607Q | 607 | Pathogenic / likely pathogenic | |
| UBE3A T679I | 679 | Pathogenic / likely pathogenic | |
| UBE3A F713C | 713 | Pathogenic / likely pathogenic |
Which prediction tools work for Angelman syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- EVE: 97 out of 100
- ESM1b (LLR): 91 out of 100
- CATVariant: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 76 out of 100
- MetaSVM: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Angelman syndrome
- Rett syndrome, also linked to CDKL5 and MECP2
- Autism, also linked to CDKL5 and MECP2
- Developmental and epileptic encephalopathy, also linked to CDKL5
- Angelman syndrome-like, also linked to CDKL5
- CDKL5 disorder, also linked to CDKL5
- Severe neonatal-onset encephalopathy with microcephaly, also linked to MECP2
- Spasms, also linked to CDKL5
- X-linked intellectual disability - psychosis - macroorchidism, also linked to MECP2
- Focal epilepsy, also linked to MECP2
- Syndromic X-linked intellectual disability Lubs type, also linked to MECP2
Frequently asked questions
Which genes have records linked to Angelman syndrome?
This view contains 3 analyzed proteins: UBE3A, CDKL5, MECP2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 30 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 106 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center